BioPharma
341 followers [0] 21 篇文章/周
Novo sees Wegovy sales rise as supply constraints ease

Third quarter sales of Novo’s in-demand obesity drug totaled $2.5 billion, roughly 81% higher than the same period in 2023 and nearly doubling the total for Lilly’s Zepbound.

Wed Nov 6, 2024 19:20
Acadia sells speedy drug review voucher for $150M

The selling price is an indication that the FDA’s planned sunsetting of the rare pediatric disease voucher program may be pushing values higher, according to one analyst. 

Wed Nov 6, 2024 18:42
Moderna said to shuffle sales leadership; Vertex records first Casgevy sale

Stephen Hoge will now oversee vaccine sales at Moderna, per a Bloomberg report. Elsewhere, Intra-Cellular unveiled an ambitious sales target and Syndax inked a lucrative royalty deal.

Wed Nov 6, 2024 18:42
Moderna reshuffles sales leadership; Vertex records first Casgevy sale

Stephen Hoge will now oversee vaccine sales at Moderna, per a Bloomberg report. Elsewhere, Intra-Cellular unveiled an ambitious sales target and Syndax inked a lucrative royalty deal.

Wed Nov 6, 2024 18:11
An RNAi renaissance is creating a new generation of startups

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the drugmaking technology in new directions.

Wed Nov 6, 2024 16:30
Cancer cell therapy from Arcellx, Gilead shows promise in early data

The companies’ CAR-T seemed to cause fewer movement disorders in a multiple myeloma trial than J&J's Carvykti has in other tests, although Wall Street analysts were divided on how the two drugs compare.

Tue Nov 5, 2024 19:21

打造你的专属新闻订阅源

准备好了吗?
开始 14 天试用,无需信用卡。

创建账号